ORAL BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE

被引：17
|
作者：
TAYLOR, WB
BATEMAN, DN
机构：
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 31卷 / 01期
关键词：
D O I：
10.1007/BF00870983
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：41 / 44
页数：4
相关论文
共 50 条
  • [31] HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS
    AASEBO, U
    SLORDAL, L
    PRYTZ, PS
    AARBAKKE, J
    PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05): : 337 - 339
  • [32] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE IN CYTOSTATIC CHEMOTHERAPY
    SCHUTTE, J
    NIEDERLE, N
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (18) : 720 - 720
  • [33] HIGH-DOSE ORAL AND INTRAVENOUS METOCLOPRAMIDE IN DOXORUBICIN CYCLOPHOSPHAMIDE-INDUCED EMESIS - A RANDOMIZED DOUBLE-BLIND-STUDY
    EDGE, SB
    FUNKHOUSER, WK
    BERMAN, A
    SEIPP, C
    TANNER, A
    WESLEY, R
    ROSENBERG, SA
    CHANG, AE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 257 - 263
  • [34] COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY
    GRUNBERG, SM
    GALA, KV
    LAMPENFELD, M
    JAMIN, D
    JOHNSON, K
    CARIFFE, P
    STRYCH, D
    KRAILO, M
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) : 782 - 787
  • [35] BIOAVAILABILITY OF LOW-DOSE VS HIGH-DOSE 6-MERCAPTOPURINE
    ARNDT, CAS
    BALIS, FM
    MCCULLY, CL
    JEFFRIES, SL
    DOHERTY, K
    MURPHY, R
    POPLACK, DG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 588 - 591
  • [36] HIGH-DOSE METOCLOPRAMIDE + LORAZEPAM VERSUS LOW-DOSE METOCLOPRAMIDE + LORAZEPAM + DEHYDROBENZPERIDOL IN THE TREATMENT OF CISPLATIN-INDUCED NAUSEA AND VOMITING
    HERRSTEDT, J
    HANNIBAL, J
    HALLAS, J
    ANDERSEN, E
    LAURSEN, LC
    HANSEN, M
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 223 - 227
  • [37] A RANDOMIZED DOUBLE-BLIND-STUDY OF HIGH-DOSE INTRAVENOUS PROCHLORPERAZINE VERSUS HIGH-DOSE METOCLOPRAMIDE AS ANTIEMETICS FOR CANCER-CHEMOTHERAPY
    OLVER, IN
    WOLF, M
    LAIDLAW, C
    BISHOP, JF
    COOPER, IA
    MATTHEWS, J
    SMITH, R
    BUCHANAN, L
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (11) : 1798 - 1802
  • [38] ABSOLUTE BIOAVAILABILITY OF A NEW HIGH-DOSE METHYLPREDNISOLONE TABLET FORMULATION
    GROENEWOUD, G
    HUNDT, HKL
    LUUS, HG
    MULLER, FO
    SCHALL, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (12) : 652 - 654
  • [39] High-dose oral tacrolimus pediatric ingestion
    Kessler, Benjamin D.
    Chan, Siu-Pun
    Majlesi, Nima
    CLINICAL TOXICOLOGY, 2015, 53 (07) : 744 - 745
  • [40] VALUE OF HIGH-DOSE METOCLOPRAMIDE FOR PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND EMESIS
    RAVAUD, A
    SEMAINE DES HOPITAUX, 1990, 66 (13): : 705 - 712
12345